🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

9 recruiting trials

for Non-muscle Invasive Bladder Cancer With Carcinoma in Situ

LEGEND Study: EG-70 in NMIBC Patients BCG-Unresponsive and High-Risk NMIBC Incompletely Treated With BCG or BCG-Naïve NCT04752722Phase 1, Phase 2102 sites📍 Birmingham📍 Scottsdale📍 Tucson enGene, Inc. · Tests: EG-70 (phase 1), EG-70 (phase 2) Master Protocol, Surfactant Bladder Pre-Rinse and EG-70 (Substudy) Efficacy and Safety of Intravesical TARA-002 Compared With Investigator's Choice of Intravesical Chemotherapy in Participants With BCG-naïve High-grade Non-muscle Invasive Bladder Cancer NCT07480356Phase 311 sites📍 Queen Creek📍 Little Rock📍 Bakersfield Protara Therapeutics · Tests: TARA-002, Investigator's Choice of Intravesical Chemotherapy Study of Cretostimogene Given in Patients With Non-Muscle Invasive Bladder Cancer ,Unresponsive to Bacillus-Calmette-Guerin NCT07283835Phase 214 sites📍 Beijing📍 Chongqing📍 Fuzhou Lepu Biopharma Co., Ltd. · Tests: Cretostimogene Grenadenorepvec, n-dodecyl-B-D-maltoside A Phase 1 Dose-escalation Study of UGN-501 Administered Intravesically in Adult Participants With Recurrent NMIBC NCT07725796Phase 115 sites📍 Queen Creek📍 Bakersfield📍 Murrieta UroGen Pharma, Inc., a subsidiary of UroGen Pharma Ltd. · Tests: UGN-501 Intravesical Photodynamic Therapy ("PDT") in BCG-Unresponsive/Intolerant Non-Muscle Invasive Bladder Cancer ("NMIBC") Patients NCT03945162Phase 216 sites📍 Chicago📍 Greenwood📍 Syracuse Theralase® Technologies Inc. · Tests: Ruvidar® (TLD-1433) bladder infusion and PDT A Trial to Evaluate Intravesical Nadofaragene Firadenovec Alone or in Combination With Chemotherapy or Immunotherapy in Participants With High-grade BCG Unresponsive Non-muscle Invasive Bladder Cancer NCT06545955Phase 380 sites📍 Tucson📍 Little Rock📍 Los Angeles Ferring Pharmaceuticals · Tests: Nadofaragene Firadenovec, Gemcitabine, Docetaxel, Pembrolizumab Study on the Occurrence of Possible Relapses and on the Quality of Life in Patients Who Underwent TURBK. NCT06167356n/a1 site📍 Milan IRCCS San Raffaele A Clinical Study of Intismeran Autogene (V940) and BCG in People With Bladder Cancer (V940-011/INTerpath-011) NCT06833073Phase 289 sites📍 Bakersfield📍 Los Alamitos📍 Los Angeles Merck Sharp & Dohme LLC · Tests: Intismeran autogene, BCG Safety and Efficacy Study of Intravesical Instillation of TARA-002 in Adults With High-grade Non-muscle Invasive Bladder Cancer NCT05951179Phase 278 sites📍 Homewood📍 Phoenix📍 Queen Creek Protara Therapeutics · Tests: TARA-002
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy